Jason I. Herschkowitz

发表

Microfluidics: Inertial Microfluidic Cell Stretcher (iMCS): Fully Automated, High-Throughput, and Near Real-Time Cell Mechanotyping (Small 28/2017)

Maneesh Kumar, Xianhui Wang, Assad A. Oberai, 2017 .

Clustering microarray-derived gene lists through implicit literature relationships

Jonathan D. Wren, Charles M. Perou, Harold R. Garner, 2007, Bioinform..

Abstract 1598: LncRNA AK001796 as a therapeutic target in aggressive breast cancers

Jeffrey M. Rosen, Charles M. Perou, John S. Mattick, 2016 .

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Jeffrey M. Rosen, Charles M. Perou, Susan G. Hilsenbeck, 2009, Proceedings of the National Academy of Sciences.

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

Kakajan Komurov, Prahlad T. Ram, Prahlad T Ram, 2010, Proceedings of the National Academy of Sciences.

Mouse models of triple negative [basal-like/claudin low] breast cancer.

Jason I. Herschkowitz, J. Herschkowitz, R. Lubet, 2010, Breast disease.

Molecular Signatures of Drug Resistance

Jason I. Herschkowitz, K. Hoadley, M. Troester, 2009 .

Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation

Jason I. Herschkowitz, D. Edwards, X. Zhang, 2016, Nature Cell Biology.

Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts

Jason I. Herschkowitz, G. Wahl, C. Perou, 2013, Genome Biology.

Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers

Jason I. Herschkowitz, E. Mardis, C. Perou, 2016, Disease Models & Mechanisms.

Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice

Jason I. Herschkowitz, C. Perou, M. Cheang, 2013, Clinical Cancer Research.

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Jason I. Herschkowitz, C. Fan, C. Perou, 2010, Breast Cancer Research.

Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Jason I. Herschkowitz, C. Perou, V. Weigman, 2010, The Journal of clinical investigation.

Characterization of mammary tumors from Brg1 heterozygous mice

Jason I. Herschkowitz, C. Perou, V. Godfrey, 2008, Oncogene.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

Zhiyuan Hu, Charles M Perou, Jason I. Herschkowitz, 2007, Genome Biology.

RB1 and p53 at the crossroad of EMT and triple-negative breast cancer

Jason I. Herschkowitz, C. Perou, T. Deng, 2011, Cell cycle.

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1

Jason I. Herschkowitz, C. Perou, A. Robles, 2008, Molecular Cancer.

Small players with big roles: microRNAs as targets to inhibit breast cancer progression.

Jason I. Herschkowitz, J. Rosen, J. Herschkowitz, 2010, Current drug targets.

Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties

Jeffrey T. Chang, Jason I. Herschkowitz, G. Calin, 2013, Scientific Reports.

FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

Jeffrey T. Chang, Jason I. Herschkowitz, M. Shariati, 2013, Cancer research.

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells

Jason I. Herschkowitz, C. Perou, S. Hilsenbeck, 2011, Proceedings of the National Academy of Sciences.

c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer

Jason I. Herschkowitz, C. Perou, M. Cowley, 2014, Oncogene.

Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway

Jason I. Herschkowitz, C. Fan, Wei-Guo Zhu, 2022, Cell Death & Disease.

Noncoding RNAs Involved in Mammary Gland Development and Tumorigenesis: There’s a Long Way to Go

Jason I. Herschkowitz, J. Rosen, J. Herschkowitz, 2012, Journal of Mammary Gland Biology and Neoplasia.

Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers

Jason I. Herschkowitz, J. Herschkowitz, M. Hepel, 2021, International journal of molecular sciences.

The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

Jason I. Herschkowitz, S. Elledge, T. Cooper, 2011, Proceedings of the National Academy of Sciences.

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

Charles M Perou, Jason I. Herschkowitz, Xiaping He, 2008, Breast Cancer Research.

Department of Pathology, Thomas Jefferson University, Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

Jason I. Herschkowitz, Karen E. Rasmussen, C. Perou, 2020 .

Breast cancer subtypes, mouse models, and microarrays

Jason I. Herschkowitz, J. Herschkowitz, 2008 .

Department of Pathology, Thom as Jeffe rson University, Identific ation of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Jason I. Herschkowitz, Karen E. Rasmussen, C. Perou, 2007 .

Inertial Microfluidic Cell Stretcher (iMCS): Fully Automated, High-Throughput, and Near Real-Time Cell Mechanotyping.

Jason I. Herschkowitz, Aram J. Chung, A. Oberai, 2017, Small.

MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements

Jason I. Herschkowitz, C. Perou, J. Gutkind, 2011, Breast Cancer Research and Treatment.

BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.

Jason I. Herschkowitz, Ho Lam Chan, Matthew D. Smith, 2014, Cancer research.

New twists on long noncoding RNAs: from mobile elements to motile cancer cells

Jason I. Herschkowitz, J. Rosen, J. Herschkowitz, 2020, RNA biology.

Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer

Jason I. Herschkowitz, J. Herschkowitz, Rebecca S DeVaux, 2018, Journal of Mammary Gland Biology and Neoplasia.

Molecular and Cellular Changes in Breast Cancer and New Roles of lncRNAs in Breast Cancer Initiation and Progression.

Jason I. Herschkowitz, J. Herschkowitz, M. Kumar, 2016, Progress in molecular biology and translational science.

Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status.

Melissa A Troester, Katherine A Hoadley, Jason I. Herschkowitz, 2013, Carcinogenesis.

Clustering microarray-derived gene lists through implicit literature relationships

Jason I. Herschkowitz, C. Perou, Jonathan D. Wren, 2007, Bioinform..

An Organotypic Mammary Duct Model Capturing Distinct Events of DCIS Progression

Jason I. Herschkowitz, J. Herschkowitz, Rebecca S DeVaux, 2020, bioRxiv.

Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine

Jason I. Herschkowitz, J. Herschkowitz, M. Hepel, 2017, International journal of nanomedicine.

Long noncoding RNA BHLHE40‐AS1 promotes early breast cancer progression through modulating IL‐6/STAT3 signaling

Jason I. Herschkowitz, William P. Smith, C. Coarfa, 2020, Journal of cellular biochemistry.

Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion

Jason I. Herschkowitz, William P. Smith, D. Carrasco, 2015, Breast Cancer Research.